The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Discovery of Common Urinary Biomarkers for Hepatotoxicity Induced by Carbon Tetrachloride, Acetaminophen and Methotrexate by Mass Spectrometry-Based Metabolomics
Abstract
Liver toxicity represents an important healthcare issue because it causes significant morbidity and mortality and can be difficult to predict before symptoms appear owing to drug therapy or exposure to toxicants. Using metabolomic techniques, we discovered common biomarkers for the prediction of hepatotoxicity in rat urine using mass spectrometry. For this purpose, liver toxicity was induced by 5 days of oral administration of carbon tetrachloride (1 ml kg−1 per day), acetaminophen (1000 mg kg−1 per day) and methotrexate (50 mg kg−1 per day). Serum levels of alkaline phosphatase aspartate aminotransferase, alanine aminotransferase and histopathology in liver tissue were then checked to demonstrate liver toxicity. Global metabolic profiling with UPLC‐TOF‐MS (ultraperformance liquid chromatography–mass spectrometry), multivariate analysis (partial least square‐discriminant analysis, hierarchical analysis) and database searching were performed to discover common biomarkers for liver toxicity induced by these three compounds. Urinary concentrations of the newly discovered biomarkers were then quantified to confirm them as biomarkers of hepatotoxicity with targeted metabolic profiling using GC (gas chromatography)–MS and CE (capillary electrophoresis)–MS. In the results, steroids, amino acids and bile acids were metabolically changed between the control and drug‐treated groups in global metabolic profiling; 11 β‐hydroxyandrosterone, epiandrosterone, estrone, 11‐dehydrocorticosterone, glycine, alanine, valine, leucine, dl‐ornithine, 3‐methylhistidine, cholic acid and lithocholic acid were selected as liver toxicity biomarkers after performing targeted metabolic profiling. In conclusion, we discovered metabolite biomarkers belonging to three different metabolic pathways to check for liver toxicity with mass spectrometry from a metabolomics study that could be used to evaluate hepatotoxicity induced by drugs or other toxic compounds. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various animal studies and in vitro models have identified changes in the metabolomic profile in the presence of DILI [13,16,22,23,24,25,26,27,28,29,30,31,32,33,34,35].”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [23]
Citations
Cites
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Flagged first, then by citations
Research works printed but not linked: 81
- 10.1046/j.1440‐1681.1999.03052.x · DOI
- 10.1111/j.1447‐073X.2006.00129.x · DOI
- 10.1093/toxsci/kfn268 · DOI
- 10.1517/14740338.6.4.341 · DOI
- Bales JR, 1984, Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy, Clin. Chem., 30, 1631, 10.1093/clinchem/30.10.1631 · DOI
- 10.1002/mrm.1910060308 · DOI
- 10.1053/jhep.1996.v23.pm0008621149 · DOI
- 10.1007/s11306‐009‐0159‐1 · DOI
- 10.1016/j.taap.2009.11.019 · DOI
- 10.1080/20014091111677 · DOI
- 10.1016/j.jchromb.2008.05.008 · DOI
- 10.1093/brain/awm304 · DOI
- 10.1172/JCI116511 · DOI
- 10.3109/00365528009182221 · DOI
- 10.1111/j.1440‐1746.2006.04595.x · DOI
- 10.1016/j.ygcen.2010.03.027 · DOI
- 10.1021/tx0256127 · DOI
- 10.1016/j.jpba.2003.12.019 · DOI
- 10.1080/01926230590522428 · DOI
- 10.1016/j.bcp.2008.12.023 · DOI
- 10.1124/dmd.107.017533 · DOI
- 10.1002/hep.20957 · DOI
- 10.1016/0026-0495(73)90269-2 · DOI
- Fowler B, 2001, The folate cycle and disease in humans, Kidney Int. Suppl., 78, S221, 10.1046/j.1523-1755.2001.59780221.x · DOI
- 10.1172/JCI102686 · DOI
- 10.1021/tx950153d · DOI
- 10.1016/j.jpba.2006.12.034 · DOI
- 10.1016/j.jchromb.2008.04.034 · DOI
- 10.1016/j.phymed.2009.01.008 · DOI
- 10.1159/000468779 · DOI
- 10.1124/dmd.108.021279 · DOI
- 10.1002/1097-0142(196604)19:4<600::AID-CNCR2820190420>3.0.CO;2-3 · DOI
- 10.3109/03602539509029816 · DOI
- 10.1016/j.jchromb.2008.05.049 · DOI · Paper page
- 10.1016/j.jchromb.2005.07.049 · DOI
- 10.1007/s00228‐008‐0492‐8 · DOI
- 10.1038/clpt.2008.132 · DOI
- 10.2217/14622416.8.7.731 · DOI
- Kobayashi K, 2000, Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate, Clin. Cancer Res., 6, 3297
- 10.1002/art.20278 · DOI
- 10.1016/j.aca.2009.11.063 · DOI
- 10.1016/j.ab.2010.09.031 · DOI
- 10.1002/hep.20948 · DOI
- 10.1016/j.fct.2008.01.017 · DOI
- 10.1177/1091581809340329 · DOI
- 10.1002/hep.20293 · DOI
- 10.1016/j.tox.2008.11.018 · DOI
- 10.1016/j.jchromb.2007.10.022 · DOI
- Mallette LE, 1969, Effects of glucagon on amino acid transport and utilization in the perfused rat ler, J. Biol. Chem., 244, 5724, 10.1016/S0021-9258(18)63619-1 · DOI
- 10.1080/10590500701569398 · DOI
- 10.1080/10408440701215233 · DOI
- Michelson S, 2000, Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data‐rich landscape, Curr. Opin. Mol. Ther., 2, 651
- 10.1016/j.jasms.2009.04.020 · DOI
- 10.1016/0024-3205(76)90345-3 · DOI
- 10.1016/0959-8049(95)00216-6 · DOI
- 10.1001/archinte.1964.00280080027006 · DOI
- 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- 10.1146/annurev.pharmtox.45.120403.100058 · DOI
- Pingale SS, 2010, Hepatoprotection by Acacia catechu in CCl4 induced liver dysfunction, Int. J. Pharm. Sci. Rev. Res., 5, 150
- 10.1111/j.1365-2125.1980.tb01825.x · DOI
- 10.1093/toxsci/kfi102 · DOI
- 10.1080/030097402320817040 · DOI
- 10.1053/jhep.2003.50256 · DOI
- 10.1016/j.brainresbull.2009.10.006 · DOI
- 10.1016/j.jchromb.2008.01.027 · DOI
- 10.1007/s00383‐007‐2070‐z · DOI
- 10.1021/bi00450a028 · DOI
- 10.1042/bj1540507 · DOI
- 10.1016/j.jchromb.2008.04.008 · DOI
- 10.1128/JB.00926‐06 · DOI
- 10.1016/0163-7258(93)90023-7 · DOI
- Urschel KL, 2007, Coadministration of ornithine and alpha‐ketoglutarate is no more effective than ornithine alone as an arginine precursor in piglets enterally fed an arginine‐deficient diet, J. Nutr., 137, 55, 10.1093/jn/137.1.55 · DOI
- Outryve S, 2002, Methotrexate‐associated liver toxicity in a patient with breast cancer: case report and literature review, Neth. J. Med., 60, 216
- 10.1016/j.toxlet.2007.05.021 · DOI
- 10.1007/s00415‐009‐5115‐5 · DOI
- 10.1073/pnas.031465498 · DOI
- 10.1073/pnas.191003598 · DOI
- Widemann BC, 2000, Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4‐diamino‐N(10)‐methylpteroic acid, J. Pharmacol. Exp. Ther., 294, 894, 10.1016/S0022-3565(24)39150-5 · DOI
- 10.1021/pr049769r · DOI
- 10.1021/tx800225q · DOI
- 10.1016/j.cbi.2004.01.006 · DOI · Paper page
Cited by
Sorted by citations
Andújar-Vera, F., Alés-Palmer, M. L., Muñoz-de-Rueda, P., Iglesias-Baena, I., & Ocete-Hita, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713562 · Cited by 10
Metadata
- Authors
- Kumar, B. S., Chung, B. C., Kwon, O., & Jung, B. H.
- Affiliations
- Biomolecular Functional Research Center Korea Institute of Science and Technology PO Box 131 Cheongryang Seoul 130‐650 Republic of Korea
- Doping Control Center Korea Institute of Science and Technology PO Box 131 Cheongryang Seoul 130‐650 Republic of Korea
- Venue
- Journal of Applied Toxicology
- Publisher
- Wiley
- Published
- 2011-12
- Volume
- 32
- Issue
- 7
- Pages
- 505-520
- ISSN
- 0260-437X
- 1099-1263
- Cited by
- 52
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review